Results 201 to 210 of about 222,704 (323)

The overlooked burden: anti-seizure medications, laxatives, and antipsychotics prescribed in primary care for people with intellectual disability. [PDF]

Front Psychiatry
Laugharne R, Wilson I, Wilcock M, Shankar R.   +3 more
europepmc   +1 more source

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

Treating hearts and minds: adverse cardiovascular effects of psychiatric medications. [PDF]

Ther Adv Drug Saf
Raja AS, Leslie SJ, Buist E, Rushworth GF, Megson IL, McNamara N.   +5 more
europepmc   +1 more source

Trajectories of Suicidal Risk Impact Mood Regulation Differently in Patients With a Diagnosis of Bipolar Disorder

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Bipolar disorder (BD) carries a suicide risk 20 times higher than the general population, with up to 60% of patients attempting suicide. Current interventions have failed to reduce its incidence; static factors have shown limited predictive utility.
Abigail Ortiz, Ramzi Halabi, Daniel Blumberger, Christina Gonzalez‐Torres, Arend Hintze, Muhammad I. Husain, Mirkamal Tolend, Juveria Zaheer, Martin Alda, Benoit H. Mulsant   +9 more
wiley   +1 more source

Corrigendum to "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". [PDF]

Ther Adv Psychopharmacol
europepmc   +1 more source

The role of psychotropic medication, alcohol, illicit drugs, and suicidal intention in fatal motor vehicle accidents involving drivers with psychotic disorders. [PDF]

Eur J Public Health
Koskinen J, Hakko H, Riipinen P, Sihvola N, Halt AH.   +4 more
europepmc   +1 more source

Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial [PDF]

, 2006
Priebe, S, Rohricht, F
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Forensic postmortem findings for sudden unexplained death in schizophrenia: case series and literature review. [PDF]

Front Psychiatry
Chen Y, Yan F.
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source